This white paper examines the traceability requirements placed on tissue establishments by the Human Tissue Act 2004 and the Human Tissue Authority's (HTA) licensing and inspection framework. It discusses the practical challenges of maintaining donor-to-recipient traceability using traditional methods, and explores how purpose-built electronic systems can help establishments achieve and sustain compliance with confidence.
The Human Tissue Act 2004 (HT Act) was introduced in response to public concern over the retention and use of human organs and tissue without proper consent — most notably following the inquiries at Alder Hey Children's Hospital and Bristol Royal Infirmary in the late 1990s. The Act established the Human Tissue Authority (HTA) as the independent regulator responsible for licensing and inspecting organisations that store and use human tissue in England, Wales, and Northern Ireland.
Under the HT Act, any establishment that removes, stores, or uses human tissue for scheduled purposes — including research, transplantation, post-mortem examination, anatomical examination, and public display — must hold an appropriate HTA licence. The Act places particular emphasis on consent, governance, traceability, and quality systems. Failure to comply can result in enforcement action, licence conditions, or — in the most serious cases — criminal prosecution.
For tissue establishments specifically (those involved in the procurement, testing, processing, preservation, storage, and distribution of human tissues and cells intended for human application), the HTA also implements the requirements of the EU Tissue and Cells Directives (2004/23/EC, 2006/17/EC, and 2006/86/EC), which mandate full donor-to-recipient traceability, a robust quality management system, and the ability to trace any tissue or cell product back through every stage of its journey.
The HTA publishes a set of Standards against which licensed establishments are inspected. These Standards are organised around several key areas, but from a traceability perspective the most critical requirements include:
Donor-to-recipient traceability. Establishments must be able to trace tissues and cells from the donor through every stage of procurement, testing, processing, storage, and distribution to the recipient — and vice versa. This traceability must be maintained for a minimum of 30 years after clinical use or expiry.
Unique identification. Every donation and every product derived from it must be given a unique identifier. The HTA expects establishments to use the Single European Code (SEC) or an equivalent coding system that links the donation, the tissue establishment, and the product type.
Audit trails. All records relating to traceability — including who created, modified, or accessed a record — must be maintained in a way that permits reconstruction of the full history. The HTA expects audit trails to be tamper-evident and to record the date, time, and identity of the user responsible for each change.
Quality management. Establishments must maintain a quality management system that covers standard operating procedures (SOPs), staff training, equipment validation, non-conformance handling, and corrective and preventive actions (CAPAs). Traceability records form a critical part of this system.
Adverse event and reaction reporting. When a serious adverse event or reaction occurs, the establishment must be able to rapidly trace all tissues and cells involved — identifying every donor and recipient connected to the affected material. The HTA requires this information to be reported within defined timeframes.
Many tissue establishments — particularly smaller organisations, university research groups, and NHS hospital departments — have historically relied on paper-based systems, laboratory notebooks, or general-purpose tools such as Microsoft Excel to manage their traceability records. While these approaches can work at a basic level, they present significant risks as the volume and complexity of tissue handling grows.
Paper records are vulnerable to loss, damage, and degradation over a 30-year retention period. They are difficult to search, making it time-consuming to trace a specific sample or respond to an adverse event report. They provide no built-in audit trail, meaning that any alterations to records may go undetected. And they make it extremely difficult to demonstrate compliance during an HTA inspection, where inspectors expect to see rapid, verifiable access to complete traceability data.
Spreadsheets carry many of the same risks. They are prone to accidental overwriting, offer no native record of who changed what, and become unwieldy as datasets grow. A 2016 study published in Genome Biology found that nearly 20% of genetics papers contained errors introduced by spreadsheet auto-formatting — a finding that underscores the broader reliability concerns with using generic tools for critical regulated data.
A purpose-built electronic traceability system — such as a tissue-specific Laboratory Information Management System (LIMS) or sample management platform — can address each of the HTA's core requirements in a way that paper and spreadsheets cannot.
Complete chain of custody. Electronic systems record every movement and transformation of a tissue sample automatically. From the moment a donation is recorded, through each processing step, storage location change, and eventual distribution or disposal, every event is captured with a timestamp and user identity. This creates an unbroken chain of custody that can be retrieved instantly.
Tamper-evident audit trails. Modern traceability platforms maintain a full history log for every record. Any change to a sample's data — whether a correction, a status update, or a location transfer — is recorded alongside the previous value, the new value, the user who made the change, and the date and time. This audit trail cannot be edited or deleted by end users, satisfying the HTA's expectation of tamper-evident record keeping.
Rapid traceability lookback. In the event of a serious adverse event or reaction, electronic systems allow establishments to run a lookback within minutes rather than hours or days. By searching on a donor identifier, a product code, or a recipient record, all connected samples and recipients can be identified immediately — a critical capability when patient safety is at stake.
Secure, long-term storage. Electronic records can be backed up, replicated, and stored securely for the required 30-year retention period. Unlike paper, digital records do not degrade, and modern systems support both cloud-hosted and on-premise deployment to suit each establishment's data governance requirements.
Role-based access and user accountability. Electronic systems enforce role-based access control, ensuring that only authorised personnel can view, edit, or approve records. Every action is tied to an individual user account — not a shared login — which provides the level of accountability that HTA inspectors expect.
HTA inspections are a reality for every licensed establishment. Inspectors will examine traceability records, audit trails, quality documentation, and staff competency as part of their assessment. Establishments that rely on manual systems often report that inspection preparation is stressful and time-consuming — pulling together paper files, cross-referencing spreadsheets, and hoping that nothing has been mislaid.
An electronic system changes this experience fundamentally. Because all data is stored in a single, searchable platform with built-in audit trails, establishments can respond to inspector queries in real time. Reports can be generated on demand, traceability chains can be demonstrated with a few clicks, and evidence of quality management activities (training records, SOPs, CAPAs) can be presented in a structured, professional format.
Several Pro-curo clients have reported that HTA inspectors have commented positively on the clarity and completeness of the records produced by the system — and that the time spent preparing for inspections has reduced significantly since moving away from paper-based processes.
The Human Tissue Act and the HTA's licensing framework set a high bar for traceability, audit trails, and quality management. While paper-based systems and spreadsheets may have sufficed in the past, the increasing complexity of tissue handling, the 30-year data retention requirement, and the expectation of rapid lookback capability make electronic traceability systems not just preferable but increasingly essential.
A purpose-built tissue traceability platform provides the complete chain of custody, tamper-evident audit trail, and rapid reporting capability that the HTA expects — while also reducing the administrative burden on staff and improving the overall efficiency of the tissue establishment. For any organisation currently relying on manual methods, the transition to an electronic system is one of the most impactful steps it can take towards sustained HTA compliance.
